Dr. Përparim Limani, MD, PhD, FACS, FEBS

Dr. Përparim Limani, MD, Ph.D., FACS, FEBS, after studying medicine and completing his MD doctorate at the Faculty of Medicine at the University of Zurich/Switzerland, Përparim Limani performed his specialist training in surgery at the University Hospital of Zurich. He successfully completed his research fellowship at the Swiss Hepato-Pancreato-Biliary (HPB) Laboratory in Zurich (under the supervision of Prof. Pierre-Alain Clavien) with a Ph.D. doctorate at the Faculty of Sciences. His research focus is on novel therapeutic approaches in gastrointestinal neoplasm, liver regeneration, ischemia-reperfusion injury of the liver, and therapeutic targeting of the tumor microenvironment and tumor hypoxia. These preclinical and clinical studies have been published in prestigious Journals such as Nature Communications, Annals of Surgery, and Clinical Cancer Research. The scientific work has been presented at various national and international meetings and awarded with numerous prizes for the best scientific contribution.

Additionally, Dr. Limani completed postgraduate training in pharmaceutical medicine and clinical trials management. Dr. Limani holds a Master of Advanced Studies in Medical Drug Development from the University of Basel/Switzerland. After a clinical fellowship in Surgical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, U.S.A., and following completion of the European Board of Surgery Qualification (EBSQ) he was awarded Fellow of the European Board of Surgery (FEBS) in Surgical Oncology and Fellow of the American College of Surgeons (FACS). Currently, he is an attending physician at the Department of Surgery and Transplantation at the University Hospital Zurich. Dr. Limani obtained his habilitation at the University of Zurich and has since been a lecturer at the Faculty of Medicine.


Forgotten Password?